Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential.
作者： Ana Marta de Matos , Maria Paula de Macedo , Amélia Pilar Rauter
DOI: 10.1002/MED.21440
关键词:
摘要: Type 2 diabetes (T2D) and Alzheimer's disease (AD) are two age‐related amyloid diseases that affect millions of people worldwide. Broadly supported by epidemiological data, the …
sci-hub.se 
researchgate.net 参考文章(481)
Yun-Zhao Tang, Gang Wang, Zhen-Huan Jiang, Tian-Tian Yan, Yi-Jun Chen, Min Yang, Ling-Ling Meng, Yan-Juan Zhu, Chen-Guang Li, Zhu Li, Ping Yu, Chang-Lin Ni, Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent Diabetology & Metabolic Syndrome. ,vol. 7, pp. 91- 91 ,(2015) , 10.1186/S13098-015-0087-3
Mudasir Maqbool, Mohammad Mobashir, Nasimul Hoda, Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease European Journal of Medicinal Chemistry. ,vol. 107, pp. 63- 81 ,(2016) , 10.1016/J.EJMECH.2015.10.018
Mennatallah A Ali, Hanan S El-Abhar, Maher A Kamel, Ahmed S Attia, None, Antidiabetic Effect of Galantamine: Novel Effect for a Known Centrally Acting Drug PLOS ONE. ,vol. 10, pp. e0134648- ,(2015) , 10.1371/JOURNAL.PONE.0134648
M. Cuadrado-Tejedor, C. Garcia-Barroso, J. Sanzhez-Arias, S. Mederos, O. Rabal, A. Ugarte, R. Franco, M. Pascual-Lucas, V. Segura, G. Perea, J. Oyarzabal, A. Garcia-Osta, Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer’s disease Clinical Epigenetics. ,vol. 7, pp. 108- 108 ,(2015) , 10.1186/S13148-015-0142-9
Kaleena Jackson, Gustavo A. Barisone, Elva Diaz, Lee-way Jin, Charles DeCarli, Florin Despa, Amylin deposition in the brain: A second amyloid in Alzheimer disease? Annals of Neurology. ,vol. 74, pp. 517- 526 ,(2013) , 10.1002/ANA.23956
Ronn S. Friedlander, Catherine E. Moss, Jessica Mace, Helen E. Parker, Gwen Tolhurst, Abdella M. Habib, Sebastian Wachten, Dermot M. Cooper, Fiona M. Gribble, Frank Reimann, Role of phosphodiesterase and adenylate cyclase isozymes in murine colonic glucagon-like peptide 1 secreting cells. British Journal of Pharmacology. ,vol. 163, pp. 261- 271 ,(2011) , 10.1111/J.1476-5381.2010.01107.X
H.F. Zhao, N. Li, Q. Wang, X.J. Cheng, X.M. Li, T.T. Liu, Resveratrol decreases the insoluble Aβ1-42 level in hippocampus and protects the integrity of the blood-brain barrier in AD rats Neuroscience. ,vol. 310, pp. 641- 649 ,(2015) , 10.1016/J.NEUROSCIENCE.2015.10.006
Paolo Gresele, Stefania Momi, Emanuela Falcinelli, Anti-platelet therapy: phosphodiesterase inhibitors. British Journal of Clinical Pharmacology. ,vol. 72, pp. 634- 646 ,(2011) , 10.1111/J.1365-2125.2011.04034.X
Shengnan Wei, Wei Li, Yang Yu, Fan Yao, Lixiang A, Xiaoxin Lan, Fengying Guan, Ming Zhang, Li Chen, Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5′monophosphate kinase: A study in vitro and in vivo Life Sciences. ,vol. 139, pp. 8- 15 ,(2015) , 10.1016/J.LFS.2015.07.032
W. W. Winder, Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle Journal of Applied Physiology. ,vol. 91, pp. 1017- 1028 ,(2001) , 10.1152/JAPPL.2001.91.3.1017